Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Plus Gemcitabine in Refractory Germ Cell Tumors
NCT00003518Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jan 1999
- Primary completion
- Jul 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of paclitaxel, gemcitabine in germ cell tumor (GCT), sponsored by Eastern Cooperative Oncology Group. Started Jan 1999; status: completed.
02
Drugs
paclitaxelgemcitabine
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT00003518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003518.